Chris Stoeckert

OBI dev call Feb. 13, 2023. No objections. All approve. OK to update PR accordingly.

Discussed on OBI dev call Feb. 13, 2023. Another option is to create a more general class as parent to this to capture non-organisms (material entities in general). Point made...

Here are ones that I noticed so far. Am reaching out to others to collect more. cco:has_familial_relationship_to cco:prescribes Designates (IAO) Mentions (IAO) Is about (IAO) cco:has_ending_instant cco:has_starting_instant cco:occurs at

How about this change? Adjuvant treatment for cancer: a surgical treatment for cancer that involves an additional component of treatment such as chemotherapy, radiotherapy, or immunotherapy. Definition source: http://www.medicinenet.com/script/main/art.asp?articlekey=2151 Subclasses...

Treatment is defined in OGMS but not therapy and these uses fit within treatment so am arguing for sticking to that. Could be open though to alternative term: adjuvant therapy

+1 @wdduncan we discussed this some on the Nov 21, 2022 OBI call. My take is that there would not be attribute and value classes just instances of characteristics that...

Definitely these should go in RO. I think we want relations with domain and range constraints that help define how to use them for standardized modeling of characteristics and to...

We also need this for the EuPathDB ontology that supports FungiDB where we have datasets that indicate specimen collection source - sometimes a type of tree, sometimes just generally a...

P7 - automated check looks at labels, not meanings. Req: Checks that relations are from RO in an OBO ontology. Review/changes needed: If the relation is not from RO, the...

The principle and validation are both addressing the use of RO properties. Both say relations should be reused from the Relations Ontology (RO) and MUST reuse existing RO relations than...